Population Pharmacokinetic-Pharmacodynamic Modeling of Haloperidol in Patients With Schizophrenia Using Positive and Negative Syndrome Rating Scale

Journal of Clinical Psychopharmacology - United States
doi 10.1097/jcp.0b013e3182a4ee2c